StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Filana Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$28.70M. For fiscal 2025 it was -$32.25M. The highest annual figure on record is -$143.00K in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$32.25M–
FY2024Dec 31, 2024-$116.93M–
FY2023Dec 31, 2023-$82.03M–
FY2022Dec 31, 2022-$77.51M–
FY2021Dec 31, 2021-$30.20M–
FY2020Dec 31, 2020-$5.38M–
FY2019Dec 31, 2019-$2.51M–
FY2018Dec 31, 2018-$4.77M–
FY2017Dec 31, 2017-$8.24M–
FY2016Dec 31, 2016-$12.23M–
FY2015Dec 31, 2015-$9.05M–
FY2014Dec 31, 2014-$9.55M–
FY2013Dec 31, 2013-$6.95M–
FY2012Dec 31, 2012-$7.17M–
FY2011Dec 31, 2011-$260.00K–
FY2010Dec 31, 2010-$143.00K–
FY2009Dec 31, 2009-$14.69M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.86M–
Q1 FY2026Mar 31, 2026-$8.88M–
Q4 FY2025Dec 31, 2025-$9.75M–
Q3 FY2025Sep 30, 2025-$6.22M–
Q2 FY2025Jun 30, 2025-$4.95M–
Q1 FY2025Mar 31, 2025-$11.34M–
Q4 FY2024Dec 31, 2024-$61.27M–
Q3 FY2024Sep 30, 2024-$18.30M–
Q2 FY2024Jun 30, 2024-$18.24M–
Q1 FY2024Mar 31, 2024-$19.13M–
Q4 FY2023Dec 31, 2023-$22.32M–
Q3 FY2023Sep 30, 2023-$26.53M–
Q2 FY2023Jun 30, 2023-$19.92M–
Q1 FY2023Mar 31, 2023-$13.26M–
Q4 FY2022Dec 31, 2022-$21.32M–
Q3 FY2022Sep 30, 2022-$21.55M–
Q2 FY2022Jun 30, 2022-$11.11M–
Q1 FY2022Mar 31, 2022-$23.53M–
Q4 FY2021Dec 31, 2021-$7.99M–
Q3 FY2021Sep 30, 2021-$14.76M–
Q2 FY2021Jun 30, 2021-$5.14M–
Q1 FY2021Mar 31, 2021-$2.31M–
Q4 FY2020Dec 31, 2020-$1.18M–
Q3 FY2020Sep 30, 2020-$2.17M–
Q2 FY2020Jun 30, 2020-$842.00K–
Q1 FY2020Mar 31, 2020-$1.19M–
Q4 FY2019Dec 31, 2019-$589.00K–
Q3 FY2019Sep 30, 2019-$730.00K–
Q2 FY2019Jun 30, 2019-$591.00K–
Q1 FY2019Mar 31, 2019-$604.00K–
Q4 FY2018Dec 31, 2018-$565.00K–
Q3 FY2018Sep 30, 2018-$1.44M–
Q2 FY2018Jun 30, 2018-$1.13M–
Q1 FY2018Mar 31, 2018-$1.64M–
Q4 FY2017Dec 31, 2017-$1.44M–
Q3 FY2017Sep 30, 2017-$2.15M–
Q2 FY2017Jun 30, 2017-$3.20M–
Q1 FY2017Mar 31, 2017-$1.45M–
Q4 FY2016Dec 31, 2016-$3.03M–
Q3 FY2016Sep 30, 2016-$2.79M–

More Filana Therapeutics figures

See a number that looks wrong?